|
-
andrepharma3
2025-3-14
-
98
0
|
|
-
andrepharma3
2025-3-14
-
104
0
|
|
-
andrepharma3
2025-3-14
-
98
0
|
|
-
andrepharma3
2025-3-14
-
96
0
|
|
-
andrepharma3
2025-3-14
-
113
0
|
|
-
andrepharma3
2025-3-14
-
100
0
|
|
-
andrepharma3
2025-3-14
-
104
0
|
|
-
andrepharma3
2025-3-14
-
106
0
|
|
-
andrepharma3
2025-3-14
-
92
0
|
|
-
andrepharma3
2025-3-14
-
91
0
|
|
-
andrepharma3
2025-3-14
-
110
0
|
|
-
andrepharma3
2025-3-14
-
94
0
|
|
-
andrepharma3
2025-3-14
-
103
0
|
|
-
andrepharma3
2025-3-14
-
107
0
|
|
-
andrepharma3
2025-3-14
-
122
0
|
|
-
andrepharma3
2025-3-14
-
91
0
|
|
-
andrepharma3
2025-3-14
-
90
0
|
|
-
andrepharma3
2025-3-14
-
99
0
|
|
-
andrepharma3
2025-3-14
-
92
0
|
|
-
andrepharma3
2025-3-14
-
105
0
|